133 related articles for article (PubMed ID: 38382246)
1. Pediatric Ocular Myasthenia Gravis: Single-Center Experience.
Kessi M; Tang Y; Chen B; Wang G; Zhang C; He F; Peng J; Yin F; Yang L
Pediatr Neurol; 2024 Apr; 153():137-143. PubMed ID: 38382246
[TBL] [Abstract][Full Text] [Related]
2. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
3. Childhood myasthenia gravis: clinical features and outcomes.
Sri-udomkajorn S; Panichai P; Liumsuwan S
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
[TBL] [Abstract][Full Text] [Related]
5. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with insensitivity to pyridostigmine therapy in Thai patients with ocular myasthenia gravis.
Chirapapaisan N; Tanormrod S; Chuenkongkaew W
Asian Pac J Allergy Immunol; 2007 Mar; 25(1):13-6. PubMed ID: 17891917
[TBL] [Abstract][Full Text] [Related]
7. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
Mullaney P; Vajsar J; Smith R; Buncic JR
Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yields and clinical features of ocular myasthenia gravis.
Kim H; Oh SY
Medicine (Baltimore); 2021 Jun; 100(25):e26457. PubMed ID: 34160444
[TBL] [Abstract][Full Text] [Related]
9. Visual and systemic outcomes in pediatric ocular myasthenia gravis.
Pineles SL; Avery RA; Moss HE; Finkel R; Blinman T; Kaiser L; Liu GT
Am J Ophthalmol; 2010 Oct; 150(4):453-459.e3. PubMed ID: 20678749
[TBL] [Abstract][Full Text] [Related]
10. Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in China.
Feng X; Huan X; Yan C; Song J; Lu J; Zhou L; Wu H; Qiao K; Lu J; Xi J; Luo S; Zhao C
Eur Neurol; 2020; 83(2):182-188. PubMed ID: 32526733
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of pediatric ocular myasthenia gravis.
Ortiz S; Borchert M
Ophthalmology; 2008 Jul; 115(7):1245-1248.e1. PubMed ID: 18155768
[TBL] [Abstract][Full Text] [Related]
12. Clinical profiles of Thai patients with ocular myasthenia gravis in Siriraj Hospital.
Leeamornsiri S; Chirapapaisan N; Chuenkongkaew W
J Med Assoc Thai; 2011 Sep; 94(9):1117-21. PubMed ID: 21970202
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis.
Isshiki Y; Mimura O; Gomi F
Jpn J Ophthalmol; 2020 Nov; 64(6):628-634. PubMed ID: 32936398
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics Associated With Secondary Generalization in Patients With Ocular Myasthenia Gravis: A Systematic Review and Meta-analysis.
Fang CEH; Bokre D; Wong SH
Neurology; 2023 Oct; 101(16):e1594-e1605. PubMed ID: 37643888
[TBL] [Abstract][Full Text] [Related]
15. Age of onset and factors affecting treatment responses in ocular myasthenia gravis.
Kemchoknatee P; Armornpetchsathaporn A; Tangon D; Srisombut T
Int Ophthalmol; 2023 Aug; 43(8):2777-2785. PubMed ID: 36879110
[TBL] [Abstract][Full Text] [Related]
16. Ocular myasthenia gravis - How effective is low dose prednisone long term?
Verma R; Wolfe GI; Kupersmith MJ
J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
[TBL] [Abstract][Full Text] [Related]
17. Juvenile Ocular Myasthenia Gravis: Presentation and Outcome of a Large Cohort.
Vanikieti K; Lowwongngam K; Padungkiatsagul T; Visudtibhan A; Poonyathalang A
Pediatr Neurol; 2018 Oct; 87():36-41. PubMed ID: 30197221
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmologic clinical features of ocular myasthenia gravis.
Kim DH; Roh HC; Oh SY
Medicine (Baltimore); 2023 Jan; 102(2):e31972. PubMed ID: 36637960
[TBL] [Abstract][Full Text] [Related]
19. The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis.
Chung IY; Sheth SJ; Wells KK; Campbell TG
J Neuroophthalmol; 2021 Dec; 41(4):e627-e630. PubMed ID: 32868574
[TBL] [Abstract][Full Text] [Related]
20. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
